Your use of the pronoun "our" indeed suggests a connection to the company, either as an employee or an external consultant, representing the company's interests to an external audience. However, using "our" in a phrase like "our local police station" doesn't necessarily imply personal involvement, such as spending hours in an interrogation room. So, could you clarify if you have any relationship with the company, whether internal, external, contractual? or just limited a shareholder?
On a related note, the integration of multimodal processing with real-time edge processing, akin to what BrainChip (BRN) is developing, in combination with LLMs, is fascinating.
Especially when considering what I believe is the final piece needed for true AGI: a real-world physics engine. This engine, or an "intrinsic understanding of real-world behavior" replicate what most organisms even chickens posses - is a challenging though solvable particularly for Tesla FSD.
The company that successfully integrates multimodal processing, real-time processing on the edge, real-world behavior of "things" and LLMs will be at the forefront of a major industrial revolution. This synergy has the potential to create a company worth $10T multiples, possibly leading to the world's first trillionaires. Think about the impact on industries like warehouse management, mining operations, and factory production – they will be completely transformed within the next decade.
However, I remain unconvinced about APX's future prospects in this rapidly evolving landscape unless it changes tacks. The pace and scale of technological advancement in this field requires more than participation.
- Forums
- ASX - By Stock
- APX
- Multi Modal (integration of multi data types) breakthrough in 12 months
Multi Modal (integration of multi data types) breakthrough in 12 months, page-9
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APX (ASX) to my watchlist
|
|||||
Last
50.0¢ |
Change
-0.005(0.99%) |
Mkt cap ! $111.5M |
Open | High | Low | Value | Volume |
51.0¢ | 53.0¢ | 49.0¢ | $1.034M | 2.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 26979 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 0.500 |
4 | 52371 | 0.495 |
15 | 360117 | 0.490 |
7 | 101980 | 0.485 |
10 | 470902 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 26979 | 3 |
0.515 | 15117 | 2 |
0.520 | 73197 | 6 |
0.525 | 20811 | 2 |
0.530 | 140339 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online